CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 15 enrolled
Drug / intervention
CST001device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02253537
NCT02253537N/ACompleted

Evaluation of the 4th Generation QuantiFERON-TB Test (CST001) for the Detection of Tuberculosis Infection

QIAGEN Gaithersburg, Inc·observational·Posted Oct 1, 2014·Updated Jun 18, 2019

In Brief

An observational study evaluating CST001 for Tuberculosis. Completed, enrolled 15 participants across 1 site.

Detailed Summary

To compare the results of the investigational test to the currently approved QuantiFERON-TB Gold In-Tube test.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsTuberculosis
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedOct 1, 2014
Enrollment StartFeb 2, 2015
Primary CompletionApr 26, 2016
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 11.8 years ago

Interventions

CST001device